NISHITH.TV
  • Mumbai
  • Silicon Valley
  • Bengaluru
  • Singapore
  • Mumbai BKC
  • New Delhi
  • Munich
  • New York

Locations

  • Mumbai
  • Silicon Valley
  • Bengaluru
  • Singapore
  • Mumbai BKC
  • New Delhi
  • Munich
  • New York
  • Content
  • Home
  • ABOUT US
  • NDA in the Media
  • Areas of Service
  • Research and Articles
  • Opportunities
  • Contact
  • NDACloud
  • Client Access
  • Member Access
  • Events and Calender
  • How we perform
  • Knowledge anywhere, anytime
  • See our recent deals
  • Up to date legal developments
  • Case studies in M&A

Research and Articles


  • Research at NDA
  • Research Papers
  • Research Articles
  • NDA Think Tanks
  • NDA Hotline
  • New Ali Gunjan
  • Japan Desk ジャパンデスク

NDA-Hotline


  • Debt Funding in India Series
  • Private Equity Corner
  • The Startups Series
  • Court Corner
  • Investment Funds: Monthly Digest
  • Insolvency and Bankruptcy Hotline
  • Deal Destination
  • New Publication
  • M&A Interactive
  • Lit Corner
  • Private Debt Hotline
  • Food & Beverages Hotline
  • Companies Act Series
  • Gaming Law Wrap
  • Private Client Wrap
  • GIFT City Express
  • Regulatory Hotline
  • Capital Markets Hotline
  • Tax Hotline
  • Corpsec Hotline
  • Dispute Resolution Hotline
  • M&A Hotline
  • Pharma & Healthcare Update
  • Competition Law Hotline
  • HR Law Hotline
  • IP Hotline
  • Telecom Hotline
  • FEMA Hotline
  • Social Sector Hotline
  • iCe Hotline
  • SEZ Hotline
  • Media Hotline
  • Funds Hotline
  • Education Sector Hotline
  • International Trade Hotlines
  • Other Hotline
  • Real Estate Update
  • Realty Check
  • White Collar and Investigations Practice
  • Legal Update
  • IP Lab
  • Cross Examination
  • Technology & Tax Series
  • Technology Law Analysis
  • Yes, Governance Matters.
  • Financial Service Update
  • Japan Desk ジャパンデスク

Pharma & Healthcare Update

1234
TITLE 
DATE 
Rules for Compensation in Clinical Trials Related Injury, Death Notified
02-14-2013
Clinical Trials On Trial
01-30-2013
Bar Coding Requirement For Secondary Level Packaging Of Exported Medicines Enforced On January 1, 2013
01-23-2013
Launch New Drug In 6 Months Or Face Cancellation Of The License
01-18-2013
Pharma Update - II
10-23-2012
Pharma Update - I
09-14-2012
Formula for determining the quantum of compensation to clinical trials subjects proposed
08-24-2012
Compensation for injuries in clinical trials getting regulated Ethics Committee decision final
12-23-2011
FDI in Pharma stays at 100% but with certain restrictions
11-16-2011
Product promotions - Pharma companies under restrictions
08-29-2011
Clinical Trial Related Information Exempted from Disclosure
06-16-2011
Pharma Regulatory Update 2010
02-08-2011
Indian drug authorities to now visit and inspect foreign manufacturers' facilities
01-14-2011
Probiotic foods market in India soon to be regulated
12-26-2009
The noose tightens around adulterated and spurious drugs players
08-27-2009
Revised Mashelkar Committee Report on Patent Law Issues accepted by the Government
08-25-2009
Phase I trials for drugs discovered outside India take a backseat yet again
05-15-2009
Clinical Trials - Added Stringent Measures On Their Way!
04-22-2009
Pay To Participants For Research Related Injuries- Suggests ICMR
11-26-2008
Patentee to be heard in proceedings for compulsory licensing for export
07-08-2008

Mission and Vision


Distinctly Different

What's New


Mid-year Regulatory Update 2022: Pharmaceuticals in India
Pharma & Healthcare Update: June 24,2022
TCS case may throw spotlight on job termination in IT industry
Quotes : June 23,2022

Events


Webinars

Sustainable Mobility: Opportunities and Challenges
June 09,2022 - June 09,2022

This event is over. For event material please click here


Seminar

Navigating Disputes in India
February 26,2020 - February 26,2020

This event is over. For event material please click here


Round Table

Investing In Net Zero
July 14,2022 - July 14,2022

News Roundup


News Articles

Impact of Supreme Court’s new covidvaccination ruling on India’s employers
May 13,2022

Quotes

TCS case may throw spotlight on job termination in IT industry
June 23,2022

Newsletters


Pharma & Healthcare Update

Mid-year Regulatory Update 2022: Pharmaceuticals in India
June 24,2022

Regulatory Hotline

SEBI’s concerns on Algorithmic Trading by Retail Investors
June 22,2022

Technology Law Analysis

Cyber Security Due Diligence: Should investment committee and board members consider the target’s cyber security readiness before jumping in?
June 20,2022

  • Disclaimer
  • Content
  • Feedback
  • Walkthrough
  • Subscribe
Nishith Desai Associates@2016 All rights reserved.